Drug Research
Innovacyn introduces eye, ear formulations
Innovacyn, a provider of human and animal healthcare products, has added Vetericyn VF Ophthalmic Wash and Vetericyn VF Otic Rinse to its professional-strength animal healthcare...
Drug Research
Glenmark settles patent case with Daiichi, Genzyme
Glenmark Pharmaceuticals has settled patent litigation suit with Daiichi Sankyo and Genzyme in relation to its type-2 diabetes treatment Colesevelam Hydrochloride’s abbreviated new drug application...
Drug Research
RxMD signs drug development agreement with GlycoRegImmune
RxMD has collaborated with GlycoRegImmune (GRI) to develop new treatments by using GRI's novel natural killer (NK) T cell targeted technologies for autoimmune, inflammatory and...
Drug Research
Evotec, Roche collaborate to develop oncology biomarkers
Evotec has entered into an oncology research and development agreement with Roche to organize multiple protein-activity based biomarker programs for Roche's therapeutic antibodies or small...
Drug Research
Evotec and PsychoGenics Enter into a Strategic Alliance to...
Evotec AG announced that it has entered into a strategic alliance with PsychoGenics Inc. to provide integrated CNS drug discovery solutions to pharmaceutical and biotech...
Drug Research
Radius, 3M Drug Delivery Systems Sign Development Agreement for...
Radius Health, Inc. and 3M Drug Delivery Systems announced an agreement to collaborate on the development of a transdermal delivery option of BA058, Radius’ novel,...
Drug Research
Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone...
Amgen announced primary results of a pivotal Phase 3 trial ('147) demonstrating that XGEVA(TM) (denosumab) significantly increased bone metastasis-free survival for more than four months...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.